• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型2-(2-苯烷基)-1H-苯并[d]咪唑类化合物作为抗结核药物。合成、生物学评价及构效关系

Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.

作者信息

Gobis Katarzyna, Foks Henryk, Suchan Karolina, Augustynowicz-Kopeć Ewa, Napiórkowska Agnieszka, Bojanowski Krzysztof

机构信息

Department of Organic Chemistry, Medical University of Gdańsk, 107 Gen. Hallera Ave., 80-416 Gdańsk, Poland.

Department of Organic Chemistry, Medical University of Gdańsk, 107 Gen. Hallera Ave., 80-416 Gdańsk, Poland.

出版信息

Bioorg Med Chem. 2015 May 1;23(9):2112-20. doi: 10.1016/j.bmc.2015.03.008. Epub 2015 Mar 9.

DOI:10.1016/j.bmc.2015.03.008
PMID:25797161
Abstract

A series of novel 2-(2-phenalkyl)-1H-benzo[d]imidazole derivatives and analogues (2a-3l) have been synthesized and evaluated for tuberculostatic activity. Benzimidazoles substituted at the C-2 position with phenethyl, styryl and 3,5-dichlorophenethyl moiety were obtained. Compounds 2g, 2h and 2i bearing methyl groups at the benzimidazole system and phenalkyl substituent at the C-2 position showed high tuberculostatic activity against Mycobacterium tuberculosis strains with MIC values ranging from 0.8 to 6.2 μg/mL (2.5-25 μM). More importantly, derivatives 2g (5,6-dimethyl-2-phenethyl-1H-benzo[d]imidazole) and 2i (2-(3,5-dichlorophenethyl)-5,6-dimethyl-1H-benzo[d]imidazole) appeared selective for M. tuberculosis as compared with eukaryotic cells: non-malignant (neonatal human dermal fibroblasts) and malignant (mouse melanoma B16-F10 cell line). These compounds may thus represent a novel, selective class of anti-tubercular agents. SAR studies resulted in interesting conclusions on structural factors affecting tuberculostatic activity.

摘要

已合成了一系列新型的2-(2-苯烷基)-1H-苯并[d]咪唑衍生物及其类似物(2a - 3l),并对其抑菌活性进行了评估。得到了在C-2位被苯乙基、苯乙烯基和3,5-二氯苯乙基部分取代的苯并咪唑。在苯并咪唑体系带有甲基且在C-2位带有苯烷基取代基的化合物2g、2h和2i对结核分枝杆菌菌株表现出高抑菌活性,其最低抑菌浓度(MIC)值范围为0.8至6.2 μg/mL(2.5 - 25 μM)。更重要的是,与真核细胞(非恶性的新生人类皮肤成纤维细胞和恶性的小鼠黑色素瘤B16-F10细胞系)相比,衍生物2g(5,6-二甲基-2-苯乙基-1H-苯并[d]咪唑)和2i(2-(3,5-二氯苯乙基)-5,6-二甲基-1H-苯并[d]咪唑)对结核分枝杆菌具有选择性。因此,这些化合物可能代表一类新型的选择性抗结核药物。构效关系研究得出了关于影响抑菌活性的结构因素的有趣结论。

相似文献

1
Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.新型2-(2-苯烷基)-1H-苯并[d]咪唑类化合物作为抗结核药物。合成、生物学评价及构效关系
Bioorg Med Chem. 2015 May 1;23(9):2112-20. doi: 10.1016/j.bmc.2015.03.008. Epub 2015 Mar 9.
2
Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.新型1H-苯并[d]咪唑衍生物及其类似物的体外抗分枝杆菌活性的合成与评价
Eur J Med Chem. 2015 Jan 7;89:13-20. doi: 10.1016/j.ejmech.2014.10.031. Epub 2014 Oct 14.
3
Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.新型 3-环己基丙酸衍生的含氮杂环化合物的合成及其抗结核活性评价。
Bioorg Med Chem. 2012 Jan 1;20(1):137-44. doi: 10.1016/j.bmc.2011.11.020. Epub 2011 Nov 20.
4
SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents.以氟苯并咪唑为抗菌和抗结核药物的棒状[1,2,4] -三唑基的构效关系研究
Eur J Med Chem. 2009 Jul;44(7):2930-5. doi: 10.1016/j.ejmech.2008.12.001. Epub 2008 Dec 16.
5
Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives.1-[(2E)-3-苯基丙-2-烯酰基]-1H-苯并咪唑衍生物的合成、晶体研究、抗结核及细胞毒性研究
Eur J Med Chem. 2014 May 22;79:194-202. doi: 10.1016/j.ejmech.2014.04.017. Epub 2014 Apr 5.
6
Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters.新型苯并咪唑氨基酸酯的合成及其抗分枝杆菌活性评估
Eur J Med Chem. 2015 Mar 26;93:614-24. doi: 10.1016/j.ejmech.2013.06.025. Epub 2013 Jun 22.
7
1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.1H-苯并[d]咪唑和 3,4-二氢喹唑啉-4-酮:设计、合成与抗结核活性。
Eur J Med Chem. 2018 Jul 15;155:153-164. doi: 10.1016/j.ejmech.2018.06.005. Epub 2018 Jun 2.
8
Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.新型N'-(4-芳氧基亚苄基)-1H-苯并咪唑-2-碳酰肼衍生物作为抗结核药物的合成及生物学评价
Comb Chem High Throughput Screen. 2014;17(7):630-8. doi: 10.2174/1386207317666140314092412.
9
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.新型咪唑并[2,1-b][1,3,4]噻二唑-苯并咪唑衍生物的合成与生物评价。
Eur J Med Chem. 2015 May 5;95:49-63. doi: 10.1016/j.ejmech.2015.03.024. Epub 2015 Mar 14.
10
Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.具有抗结核活性的苯氧基烷基苯并咪唑类化合物的鉴定
J Med Chem. 2015 Sep 24;58(18):7273-85. doi: 10.1021/acs.jmedchem.5b00546. Epub 2015 Sep 2.

引用本文的文献

1
Oxazole and isoxazole-containing pharmaceuticals: targets, pharmacological activities, and their SAR studies.含恶唑和异恶唑的药物:靶点、药理活性及其构效关系研究
RSC Med Chem. 2025 Feb 19. doi: 10.1039/d4md00777h.
2
Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies.通过基于 3D-QSAR 的药效团建模、虚拟筛选、分子对接和分子动力学模拟研究发现具有潜在抗结核活性的新型吡唑衍生物。
Mol Divers. 2023 Aug;27(4):1547-1566. doi: 10.1007/s11030-022-10511-8. Epub 2022 Aug 15.
3
Differences in the Structure and Antimicrobial Activity of Hydrazones Derived from Methyl 4-Phenylpicolinimidate.
4-苯基吡啶甲脒甲酯衍生腙的结构与抗菌活性差异
Materials (Basel). 2022 Apr 24;15(9):3085. doi: 10.3390/ma15093085.
4
A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives.苯并咪唑衍生物药理活性研究进展综述
Front Pharmacol. 2021 Nov 3;12:762807. doi: 10.3389/fphar.2021.762807. eCollection 2021.
5
Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.抗分枝杆菌小分子药物研发管道:再利用药物和有前途的新型化学实体。
Med Res Rev. 2021 Jul;41(4):2350-2387. doi: 10.1002/med.21798. Epub 2021 Mar 1.
6
1-Benzo[]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis.苯并咪唑衍生物影响结核分枝杆菌中的 MmpL3。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00441-19. Print 2019 Oct.
7
3D QSAR-based design and liquid phase combinatorial synthesis of 1,2-disubstituted benzimidazole-5-carboxylic acid and 3-substituted-5-benzimidazo[1,2-][1,4]benzodiazepin-6(7)-one derivatives as anti-mycobacterial agents.基于3D QSAR的1,2-二取代苯并咪唑-5-羧酸和3-取代-5-苯并咪唑并[1,2 - ][1,4]苯并二氮杂卓-6(7)-酮衍生物作为抗分枝杆菌剂的设计与液相组合合成
Medchemcomm. 2019 Mar 22;10(5):817-827. doi: 10.1039/c9md00006b. eCollection 2019 May 1.
8
Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.新型含烷基、环烷基或吡啶基苯并唑类化合物的合成及抗结核活性评价。
Molecules. 2018 Apr 23;23(4):985. doi: 10.3390/molecules23040985.
9
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.新型抗结核多药耐药化合物的药物发现进展
Pharmaceuticals (Basel). 2017 Jun 1;10(2):51. doi: 10.3390/ph10020051.